Xsphera Biosciences focuses on oncology drug development and precision medicine through its innovative tumor preservation platform. This system is designed to create functional predictive assays that assess patient responses to cancer therapies. By capturing the entire tumor microenvironment, which includes immune cells, tumor cells, and stroma, Xsphera's technology allows for the storage of these components within multiple microfluidic channels. This capability enables drug developers to measure both the cytotoxic efficacy of treatments and the molecular responses, thereby enhancing the precision and effectiveness of oncology therapeutics.
NLX enables organizations to build and manage next generation conversational experiences - personalized conversations that are automated, integrated, measurable, highly scalable and available anytime and anywhere.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.